Total Valuation
MacroGenics has a market cap or net worth of CHF207.01M. The enterprise value is CHF318.75.
Market CapCHF207.01M
Enterprise ValueCHF318.75
Share Statistics
MacroGenics has 63,700,188 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,700,188
Owned by Insiders2.60%
Owned by Institutions21.48%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -32.98%.
Return on Equity (ROE)-1.34
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-32.98%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee510.24K
Profits Per Employee-254.68K
Employee Count293
Asset Turnover0.58
Inventory Turnover5.46
Valuation Ratios
The current PE Ratio of MacroGenics is ―. MacroGenics’s PEG ratio is -0.13.
PE Ratio―
PS Ratio0.68
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-1.23
Price to Operating Cash Flow-4.07
PEG Ratio-0.13
Income Statement
In the last 12 months, MacroGenics had revenue of 149.50M and earned -74.62M in profits. Earnings per share was -1.18.
Revenue149.50M
Gross Profit106.32M
Operating Income-72.84M
Pretax Income-75.29M
Net Income-74.62M
EBITDA-59.61M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was -63.72M and capital expenditures -1.82M, giving a free cash flow of -65.54M billion.
Operating Cash Flow-63.72M
Free Cash Flow-65.54M
Free Cash Flow per Share-1.03
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta5.66
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
MacroGenics upcoming earnings date is Nov 4, 2026, TBA (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 5.10, with Debt / Equity ratio of 81.85%
Current Ratio5.10
Quick Ratio4.92
Debt to Market Cap0.74
Net Debt to EBITDA-0.83
Interest Coverage Ratio-8.56
Taxes
In the past 12 months, MacroGenics has paid -672.00K in taxes.
Income Tax-672.00K
Effective Tax Rate<0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -2.54, with an EV/FCF ratio of -1.82.
EV to Sales1.01
EV to EBITDA-2.54
EV to Free Cash Flow-1.82
EV to Operating Cash Flow-1.87
Balance Sheet
MacroGenics has CHF173.31M in cash and marketable securities with CHF35.09M in debt, giving a net cash position of CHF138.21M billion.
Cash & Marketable SecuritiesCHF173.31M
Total DebtCHF35.09M
Net CashCHF138.21M
Net Cash Per ShareCHF2.17
Tangible Book Value Per ShareCHF0.88
Margins
Gross margin is 50.44%, with operating margin of -48.72%, and net profit margin of -49.91%.
Gross Margin50.44%
Operating Margin-48.72%
Pretax Margin-50.36%
Net Profit Margin-49.91%
EBITDA Margin-39.87%
EBIT Margin-44.67%
Analyst Forecast
The average price target for MacroGenics is CHF5.62, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF5.62
Price Target Upside― Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast-6.77%
EPS Growth Forecast64.46%